Merrimack's Mulroy on Success of Pancreatic Drug Onivyde(Audio)

The Tape - Podcast autorstwa Bloomberg Radio

Kategorie:

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Bob Mulroy, CEO of Merrimack Pharmaceuticals, on biotech earnings, consumer health and oncology, and its product pipeline. Broadcasting live from the Boston Convention and Exhibition Center.

Visit the podcast's native language site